About us
Eieling Technology Limited (hereinafter referred to as Eieling Technology) was established in 2018 and registered in Hong Kong Science Park as a representative enterprise of the Department of Biomedical Engineering of the Hong Kong Polytechnic University. Eieling Technology (Shanghai) Limited and Eieling Technology (Shenzhen) Limited were established in 2023 as wholly-owned and controlled subsidiaries of InnoTech in mainland China, focusing on developing and providing medical ultrasound solutions in the field of liver fibrosis and fatty liver.
Since its establishment, Eieling Technology has successively received funding from the Hong Kong Polytechnic University’s Technology Pilot Fund Program, and successfully joined the Hong Kong Science Park’s Biomedical Technology Incubation Program (INCU-BIO).
Eieling Technology (Shanghai) Limited and Eieling Technology (Shenzhen) Limited were established in 2023 as wholly-owned and controlled subsidiaries of Eieling in mainland China, focusing on developing and providing medical ultrasound solutions in the field of liver fibrosis and fatty liver.
Our team
Creation Team has more than 20 years of experience in medical ultrasound imaging software and hardware research and development, and brings together core members from professional backgrounds such as biomedical engineering, computer science, artificial intelligence and cloud computing, physical electronics, biomechanics, medical imaging, and business.
All core members have a master’s degree or above and have rich experience in interdisciplinary research and development, academic achievement transformation, and commercial operations; the company has won many patents and invention awards since its establishment.
2016
The first concept test machine was born
2017
The concept was realized
2018
The company was established
2023
Shanghai and Shenzhen branches were established
2023
Officially released in Hong Kong